Dihydroboldenone vs Nandrolone Phenylpropionate
A side-by-side research comparison of Dihydroboldenone and Nandrolone Phenylpropionate across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Dihydroboldenone | Nandrolone Phenylpropionate |
|---|---|---|
| Full name | Dihydroboldenone (1-Testosterone / DHB) | Nandrolone Phenylpropionate (NPP) |
| Category | Anabolic Steroids | Anabolic Steroids |
| Status | Not medically approved (controlled substance) | Prescription drug (controlled substance) |
| Mechanism | DHB is boldenone with the double bond reduced, giving a highly anabolic, non-aromatizing steroid that does not convert to estrogen or DHT. It has strong androgen-receptor binding and promotes dry, lean gains. | Same active hormone as Deca (nandrolone) but with a shorter phenylpropionate ester, giving quicker onset and faster clearance. Acts on androgen receptors with high anabolic and reduced androgenic activity. |
| Molecular weight | 288.4 Da (base) | 406.6 Da |
| Half-life | Varies by ester | ~2.5-4.5 days |
| Bioavailability | Intramuscular injection | Intramuscular injection |
| Typical dose | Lean-gain cycles (non-medical) | Variable; more frequent than Deca |
| Frequency | Per ester | Every 2-3 days |
| Route | Intramuscular injection | Intramuscular injection |
Dihydroboldenone reported benefits
- Strong lean mass gains
- No estrogen conversion
- No DHT conversion
- Dry, hard appearance
Nandrolone Phenylpropionate reported benefits
- Lean mass gains
- Faster onset than Deca
- Faster clearance (flexibility)
- Reputed joint comfort
Related comparisons
Research and educational reference only. Not medical advice.